PHF
LIVE

Serial Number

79138724

Owner

HOLDING F.I.S. S.P.A.

Filing Date

Jun 17, 2013

Add to watchlist:

No watchlists yet
View on USPTO

PHF Trademark

Serial Number: 79138724 • Registration: 4676962

PHF is a trademark filed by HOLDING F.I.S. S.P.A. on June 17, 2013. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

HOLDING F.I.S. S.P.A. (4 trademarks)

Viale Guglielmo Marconi, 63
PORDENONE (PN) I33170 , IT

Entity Type: 03

NINE TREES GROUP S.P.A. (5 trademarks)

Via BTG. Framarin 14

Entity Type: 03

Trademark Details

Filing Date

June 17, 2013

Registration Date

January 27, 2015

Published for Opposition

November 11, 2014

Cancellation Date

June 17, 2023

Goods & Services

Pharmaceutical preparations, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; veterinary preparations for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; sanitary preparations for medical purposes; dietary supplements adapted for medical or veterinary use, food for babies; dietary supplements for humans and animals; medical plasters; materials for dressings, namely, medical and surgical dressings; material for stopping teeth, dental wax; acids for pharmaceutical purposes, namely, amino acids; thermal water for medical purposes, namely, nutritionally fortified water; nutritional supplements; medicinal alcohol; anaesthetics; fumigating sticks; antibiotics; antioxidant pills for medical use; antiseptics; sanitary towels; bath preparations, medicated; balms for medical purposes; medicated confectionery; sticking plasters for medical use; adjuvants for medical purposes; collyrium; medicated compresses; chemical contraceptives; cultures of microorganisms for medical and veterinary use; depuratives for the body; digestives for pharmaceutical purposes; drugs for medical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; medicinal herbs; medicinal fungi; meal for pharmaceutical purposes; febrifuges; milk ferments for pharmaceutical purposes; chewing gum for medical purposes; insecticides; insect repellents; dietary and nutritional supplements; vitamin supplement products, namely, vitamin supplements; mineral food supplements; nutritional supplements for medical purposes; protein dietary supplements; mineral food supplements; laxatives; skin lotions for pharmaceutical purposes; skin lotions for veterinary purposes; medicines for human purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and medicines for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; medicines for dental purposes; medicines for veterinary purposes for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; serotherapeutic medicines; medicinal oils; royal jelly dietary supplements; parasiticides; lozenges for pharmaceutical purposes; pesticides; medical slimming pills; pomades for medical purposes; biological preparations for veterinary purposes, for domestic, farm and marine animals, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and biological preparations for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for pharmaceutical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for medical purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; chemical preparations for veterinary purposes, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and drugs for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary use; vitamin preparations; hemorrhoid treatment preparations; antiparasitic preparations; mothproofing preparations; anti-uric preparations; biological preparations, namely, dermatological drugs, anti-infectives for systemic use, antineoplastic and immunomodulating agents, antiparasitics, systemic hormonal preparations, excluding reproductive hormones and insulins, and biological preparations for prevention and/or treatment of diseases or conditions related to the alimentary tract and metabolism, blood and blood forming organs, cardiovascular system, genitourinary system and reproductive hormones, musculoskeletal system, nervous system, respiratory system, sensory organs; pharmaceutical preparations for skin care; diagnostic preparations for medical purposes; air purifying preparations; radioactive substances for medical purposes; sodium salts for medical purposes; medicated serums for treatment of skin, lips, hair; soporifics; radiological contrast substances for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements; herbal teas for medicinal purposes; vaccines; vermifuges, namely, medicines for expelling intestinal worms

Soaps for personal use; perfumery, essential oils, cosmetics, hair lotions; dentifrices, abrasives, namely, skin abrasive preparations; scented linen water; aromatics, namely, essential oils; depilatory wax; hair dyes; cosmetic creams; deodorants for human beings or for animals; massage gels other than for medical purposes; hair spray; lotions for cosmetic purposes; lip glosses; cotton wool for cosmetic purposes; pumice stone for personal use; pomades for cosmetic purposes; potpourris in the nature of fragrances; nail care preparations; non-medicated toiletries; perfumes; air fragrancing preparations; shampoos; sunscreen preparations

Scientific and technological services and research and design relating thereto, namely, pharmaceutical, chemical, biotechnology research and development; industrial analysis and research services in the fields of pharmaceutical and cosmetics; chemical analysis; material testing; industrial design; designing and conducting geological surveys; conducting clinical trials for others; geological prospecting; biological research; geological research; bacteriological research; chemical research; cosmetic research; physics research; research in the field of environmental protection; mechanical research; scientific research; technical research in the fields of pharmaceuticals, chemicals, and biotechnologies; chemistry services, namely, chemistry research and chemistry consultation; scientific laboratory services

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Jan 12, 2024 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jan 12, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Aug 15, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 23, 2022 INTS
INVALIDATION PROCESSED
Jul 23, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 13, 2022 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2021 NREP
CANCELLED SECTION 71
Aug 13, 2021 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 1, 2019 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 20, 2015 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 1, 2015 FICS
FINAL DISPOSITION PROCESSED
Jun 1, 2015 FIMP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 31, 2015 ADCH
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 27, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 27, 2015 R.PR
PUBLISHED FOR OPPOSITION
Nov 11, 2014 PUBO
NOTIFICATION PROCESSED BY IB
Nov 8, 2014 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 22, 2014 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 22, 2014 OP2R
NOTICE OF PUBLICATION
Oct 22, 2014 NPUB
EXAMINERS AMENDMENT MAILED
Oct 6, 2014 CNEA
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 4, 2014 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 4, 2014 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2014 XAEC
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2014 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 3, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 3, 2014 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 3, 2014 ERFR
FINAL REFUSAL MAILED
Jul 8, 2014 CNFR
FINAL REFUSAL WRITTEN
Jul 8, 2014 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 13, 2014 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2014 CRFA
ASSIGNED TO LIE
Jun 4, 2014 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 22, 2014 TROA
REFUSAL PROCESSED BY IB
Dec 25, 2013 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2013 RFCS
REFUSAL PROCESSED BY MPU
Dec 4, 2013 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 1, 2013 RFCR
NON-FINAL ACTION WRITTEN
Nov 30, 2013 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 26, 2013 MAFR
ASSIGNED TO EXAMINER
Nov 22, 2013 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 22, 2013 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 21, 2013 REPR